laninamivir license deal, page-24

all in good time for nasdaq......i always find it interesting that no one has faith in a minnow company that makes 1 blunder deal with gsk who has a market cap which reflects huge power. gsk experts beat down biota...should this be suprising.
the experience gained and the production of lani which enables them to go into the ring for round 2 (with a a huge partner to keep check on proceedings)
will pave the way for better negotiations and a ROW outcome which demands respect from the big guys this time round given it is not gsk only but major arch enemy roche. the shoe is on biotas foot this time and several sizes bigger a steel cap boot.
no on can tell me that nasdaq has not been considered....in the timeline of the tasks at hand it just has not got to this point in time. it may have been decided its not required......funding will come from the power of the product...made in US, AUS, Japan or antartica will have no bearing as it is supreme and can not be ignored.
I know nothing other than if the borad resigned and was replaced by Hotcopperites......would you be more or less confident with your investment.
everthing should be left to play out with jojo the only inclusion as a worthy honourable board member being paid a huge allowance to take over PR. (with the capt of the liberation army as his advisor/executive assistant!).